tm
Seeing Is Believing
tm
Seeing Is Believing
Gracell Biotechnologies's activity chart (see below) currently has 26 price targets and 27 ratings on display.
Analysts average stock forecasts to be materialized ratio is 70% with an average time for these price targets to be met of 376.2 days.
Most recent stock forecast was given by from WELLS FARGO on 28-Dec-2023. First documented stock forecast 02-Feb-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Mar-2023
$10
2 years 9 months 9 days ago
(28-Dec-2023)
2/2 (100%)
$0.08 (0.81%)
138
Buy Since 30-Apr-2021
$10
$-565 (-98.26%)
$10
2 years 9 months 10 days ago
(27-Dec-2023)
5/5 (100%)
$0.08 (0.81%)
1178
Buy Since 04-Apr-2022
$20
2 years 9 months 11 days ago
(26-Dec-2023)
2/2 (100%)
$13.93 (229.49%)
1239
Buy Since 08-Dec-2022
$10
$-565 (-98.26%)
$13
2 years 9 months 11 days ago
(26-Dec-2023)
4/4 (100%)
$0.08 (0.81%)
547
Buy Since 19-Oct-2023
$11
2 years 11 months 18 days ago
(19-Oct-2023)
1/2 (50%)
$8.4 (323.08%)
894
What is GRCL (Gracell Biotechnologies) average time for price targets to be met?
Which analyst most recently updated their price target on GRCL (Gracell Biotechnologies)?
Which analyst has the most public recommendations on GRCL (Gracell Biotechnologies)?
Which analyst is the currently most bullish on GRCL (Gracell Biotechnologies)?
Which analyst is the currently most reserved on GRCL (Gracell Biotechnologies)?
